The "Recently Updated" section at the top of this page shows the most recent changes
In a trial of patients with T2DM and a BMI of 27 kg/m2 or greater being treated with semaglutide injection for weight loss, clinically significant hypoglycemia (plasma glucose less than 54 mg/dL) was reported in 6.2% of semaglutide-treated patients versus 2.5% of placebo-treated patients
Individual results vary based on starting body composition, dose, diet, activity level, and genetic factors, but general patterns emerge across most users
If a deficiency is linked to a chronic condition like pernicious anemia, Crohns, or celiac disease, you might need injections for the long haul to bypass the digestive system entirely
"Vitamin status in morbidly obese patients: a cross-sectional study"